MoneyWorks4Me

Ajanta Pharma - Quaterly Results

31 Jan 2022 Evaluate
The Revenue for the quarter ended  December 2021 of Rs. 8085.80 millions grew by 10.29 % from Rs. 7331.60 millions.A slim rise of 8.20% was recorded in the Net profit for the quarter ended December 2021 to Rs. 1947.10  millions  From Rs. 1799.50 millions.The company reported a good operating profit of 2657.70 millions compared to 2484.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 8085.80 7331.60 10.29 23750.10 19705.20 20.53 27185.90 21964.20 23.77
Other Income 279.00 29.00 862.07 1113.10 1022.40 8.87 1035.70 1842.00 -43.77
PBIDT 2657.70 2484.60 6.97 8150.50 7720.70 5.57 10204.80 7169.80 42.33
Interest 7.00 21.70 -67.74 19.40 47.20 -58.90 69.00 91.00 -24.18
PBDT 2650.70 2462.90 7.63 8131.10 7673.50 5.96 10135.80 7039.60 43.98
Depreciation 307.10 279.50 9.87 908.70 820.10 10.80 1114.90 912.90 22.13
PBT 2343.60 2183.40 7.34 7222.40 6853.40 5.38 9020.90 6126.70 47.24
TAX 396.50 383.90 3.28 1372.20 1644.80 -16.57 2264.50 1715.40 32.01
Deferred Tax 66.60 24.80 168.55 130.00 163.50 -20.49 97.70 34.50 183.19
PAT 1947.10 1799.50 8.20 5850.20 5208.60 12.32 6756.40 4411.30 53.16
Equity 173.90 173.90 0.00 173.90 175.40 -0.86 173.90 175.40 -0.86
PBIDTM(%) 32.87 33.89 -3.01 34.32 39.18 -12.41 37.54 32.64 14.99
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..